Precigen to Participate in Fireside Chat

Precigen, Inc. is scheduled to participate in a fireside chat event hosted by H.C. Wainwright on March 31. This session will provide an opportunity for investors and interested parties to gain insights into the company's strategic direction and advancements in precision medicine. Precigen, a commercial-stage biopharmaceutical company, is focused on developing innovative therapies. The fireside chat is expected to highlight the company's progress and future outlook within the rapidly evolving field of personalized medicine.